Report Detail

Request for Sample of this report

Other Global CD55 Antibody Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4554189
    • |
  • 02 September, 2023
    • |
  • Global
    • |
  • Pages: NA
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global CD55 Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
The Global Info Research report includes an overview of the development of the CD55 Antibody industry chain, the market status of Immunochemistry (IHC) (Monoclonal, Polyclonal), Immunofluorescence (IF) (Monoclonal, Polyclonal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CD55 Antibody.
Regionally, the report analyzes the CD55 Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CD55 Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CD55 Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CD55 Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal, Polyclonal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CD55 Antibody market.
Regional Analysis: The report involves examining the CD55 Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CD55 Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CD55 Antibody:
Company Analysis: Report covers individual CD55 Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CD55 Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunochemistry (IHC), Immunofluorescence (IF)).
Technology Analysis: Report covers specific technologies relevant to CD55 Antibody. It assesses the current state, advancements, and potential future developments in CD55 Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CD55 Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CD55 Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal
Polyclonal
Market segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Market segment by players, this report covers
Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
Leading Biology
ProSci
Bethyl Laboratories
OriGene Technologies
Novus Biologicals
Cell Signaling Technology
Abcam
GeneTex
United States Biological
St John's Laboratory
Creative Diagnostics
Biobyt
Jingjie PTM BioLab
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CD55 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CD55 Antibody, with revenue, gross margin and global market share of CD55 Antibody from 2018 to 2023.
Chapter 3, the CD55 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CD55 Antibody market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CD55 Antibody.
Chapter 13, to describe CD55 Antibody research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of CD55 Antibody
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CD55 Antibody by Type
    • 1.3.1 Overview: Global CD55 Antibody Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global CD55 Antibody Consumption Value Market Share by Type in 2022
    • 1.3.3 Monoclonal
    • 1.3.4 Polyclonal
  • 1.4 Global CD55 Antibody Market by Application
    • 1.4.1 Overview: Global CD55 Antibody Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Immunochemistry (IHC)
    • 1.4.3 Immunofluorescence (IF)
    • 1.4.4 Immunoprecipitation (IP)
    • 1.4.5 Western Blot (WB)
    • 1.4.6 ELISA
    • 1.4.7 Others
  • 1.5 Global CD55 Antibody Market Size & Forecast
  • 1.6 Global CD55 Antibody Market Size and Forecast by Region
    • 1.6.1 Global CD55 Antibody Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global CD55 Antibody Market Size by Region, (2018-2029)
    • 1.6.3 North America CD55 Antibody Market Size and Prospect (2018-2029)
    • 1.6.4 Europe CD55 Antibody Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific CD55 Antibody Market Size and Prospect (2018-2029)
    • 1.6.6 South America CD55 Antibody Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa CD55 Antibody Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck CD55 Antibody Product and Solutions
    • 2.1.4 Merck CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Merck Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific CD55 Antibody Product and Solutions
    • 2.2.4 Thermo Fisher Scientific CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 Proteintech Group
    • 2.3.1 Proteintech Group Details
    • 2.3.2 Proteintech Group Major Business
    • 2.3.3 Proteintech Group CD55 Antibody Product and Solutions
    • 2.3.4 Proteintech Group CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Proteintech Group Recent Developments and Future Plans
  • 2.4 Aviva Systems Biology
    • 2.4.1 Aviva Systems Biology Details
    • 2.4.2 Aviva Systems Biology Major Business
    • 2.4.3 Aviva Systems Biology CD55 Antibody Product and Solutions
    • 2.4.4 Aviva Systems Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Aviva Systems Biology Recent Developments and Future Plans
  • 2.5 LifeSpan BioSciences
    • 2.5.1 LifeSpan BioSciences Details
    • 2.5.2 LifeSpan BioSciences Major Business
    • 2.5.3 LifeSpan BioSciences CD55 Antibody Product and Solutions
    • 2.5.4 LifeSpan BioSciences CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 LifeSpan BioSciences Recent Developments and Future Plans
  • 2.6 RayBiotech
    • 2.6.1 RayBiotech Details
    • 2.6.2 RayBiotech Major Business
    • 2.6.3 RayBiotech CD55 Antibody Product and Solutions
    • 2.6.4 RayBiotech CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 RayBiotech Recent Developments and Future Plans
  • 2.7 Leading Biology
    • 2.7.1 Leading Biology Details
    • 2.7.2 Leading Biology Major Business
    • 2.7.3 Leading Biology CD55 Antibody Product and Solutions
    • 2.7.4 Leading Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Leading Biology Recent Developments and Future Plans
  • 2.8 ProSci
    • 2.8.1 ProSci Details
    • 2.8.2 ProSci Major Business
    • 2.8.3 ProSci CD55 Antibody Product and Solutions
    • 2.8.4 ProSci CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 ProSci Recent Developments and Future Plans
  • 2.9 Bethyl Laboratories
    • 2.9.1 Bethyl Laboratories Details
    • 2.9.2 Bethyl Laboratories Major Business
    • 2.9.3 Bethyl Laboratories CD55 Antibody Product and Solutions
    • 2.9.4 Bethyl Laboratories CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Bethyl Laboratories Recent Developments and Future Plans
  • 2.10 OriGene Technologies
    • 2.10.1 OriGene Technologies Details
    • 2.10.2 OriGene Technologies Major Business
    • 2.10.3 OriGene Technologies CD55 Antibody Product and Solutions
    • 2.10.4 OriGene Technologies CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 OriGene Technologies Recent Developments and Future Plans
  • 2.11 Novus Biologicals
    • 2.11.1 Novus Biologicals Details
    • 2.11.2 Novus Biologicals Major Business
    • 2.11.3 Novus Biologicals CD55 Antibody Product and Solutions
    • 2.11.4 Novus Biologicals CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Novus Biologicals Recent Developments and Future Plans
  • 2.12 Cell Signaling Technology
    • 2.12.1 Cell Signaling Technology Details
    • 2.12.2 Cell Signaling Technology Major Business
    • 2.12.3 Cell Signaling Technology CD55 Antibody Product and Solutions
    • 2.12.4 Cell Signaling Technology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Cell Signaling Technology Recent Developments and Future Plans
  • 2.13 Abcam
    • 2.13.1 Abcam Details
    • 2.13.2 Abcam Major Business
    • 2.13.3 Abcam CD55 Antibody Product and Solutions
    • 2.13.4 Abcam CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Abcam Recent Developments and Future Plans
  • 2.14 GeneTex
    • 2.14.1 GeneTex Details
    • 2.14.2 GeneTex Major Business
    • 2.14.3 GeneTex CD55 Antibody Product and Solutions
    • 2.14.4 GeneTex CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 GeneTex Recent Developments and Future Plans
  • 2.15 United States Biological
    • 2.15.1 United States Biological Details
    • 2.15.2 United States Biological Major Business
    • 2.15.3 United States Biological CD55 Antibody Product and Solutions
    • 2.15.4 United States Biological CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 United States Biological Recent Developments and Future Plans
  • 2.16 St John's Laboratory
    • 2.16.1 St John's Laboratory Details
    • 2.16.2 St John's Laboratory Major Business
    • 2.16.3 St John's Laboratory CD55 Antibody Product and Solutions
    • 2.16.4 St John's Laboratory CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 St John's Laboratory Recent Developments and Future Plans
  • 2.17 Creative Diagnostics
    • 2.17.1 Creative Diagnostics Details
    • 2.17.2 Creative Diagnostics Major Business
    • 2.17.3 Creative Diagnostics CD55 Antibody Product and Solutions
    • 2.17.4 Creative Diagnostics CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Creative Diagnostics Recent Developments and Future Plans
  • 2.18 Biobyt
    • 2.18.1 Biobyt Details
    • 2.18.2 Biobyt Major Business
    • 2.18.3 Biobyt CD55 Antibody Product and Solutions
    • 2.18.4 Biobyt CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Biobyt Recent Developments and Future Plans
  • 2.19 Jingjie PTM BioLab
    • 2.19.1 Jingjie PTM BioLab Details
    • 2.19.2 Jingjie PTM BioLab Major Business
    • 2.19.3 Jingjie PTM BioLab CD55 Antibody Product and Solutions
    • 2.19.4 Jingjie PTM BioLab CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Jingjie PTM BioLab Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CD55 Antibody Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of CD55 Antibody by Company Revenue
    • 3.2.2 Top 3 CD55 Antibody Players Market Share in 2022
    • 3.2.3 Top 6 CD55 Antibody Players Market Share in 2022
  • 3.3 CD55 Antibody Market: Overall Company Footprint Analysis
    • 3.3.1 CD55 Antibody Market: Region Footprint
    • 3.3.2 CD55 Antibody Market: Company Product Type Footprint
    • 3.3.3 CD55 Antibody Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CD55 Antibody Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global CD55 Antibody Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global CD55 Antibody Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global CD55 Antibody Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America CD55 Antibody Consumption Value by Type (2018-2029)
  • 6.2 North America CD55 Antibody Consumption Value by Application (2018-2029)
  • 6.3 North America CD55 Antibody Market Size by Country
    • 6.3.1 North America CD55 Antibody Consumption Value by Country (2018-2029)
    • 6.3.2 United States CD55 Antibody Market Size and Forecast (2018-2029)
    • 6.3.3 Canada CD55 Antibody Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico CD55 Antibody Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe CD55 Antibody Consumption Value by Type (2018-2029)
  • 7.2 Europe CD55 Antibody Consumption Value by Application (2018-2029)
  • 7.3 Europe CD55 Antibody Market Size by Country
    • 7.3.1 Europe CD55 Antibody Consumption Value by Country (2018-2029)
    • 7.3.2 Germany CD55 Antibody Market Size and Forecast (2018-2029)
    • 7.3.3 France CD55 Antibody Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom CD55 Antibody Market Size and Forecast (2018-2029)
    • 7.3.5 Russia CD55 Antibody Market Size and Forecast (2018-2029)
    • 7.3.6 Italy CD55 Antibody Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific CD55 Antibody Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific CD55 Antibody Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific CD55 Antibody Market Size by Region
    • 8.3.1 Asia-Pacific CD55 Antibody Consumption Value by Region (2018-2029)
    • 8.3.2 China CD55 Antibody Market Size and Forecast (2018-2029)
    • 8.3.3 Japan CD55 Antibody Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea CD55 Antibody Market Size and Forecast (2018-2029)
    • 8.3.5 India CD55 Antibody Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia CD55 Antibody Market Size and Forecast (2018-2029)
    • 8.3.7 Australia CD55 Antibody Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America CD55 Antibody Consumption Value by Type (2018-2029)
  • 9.2 South America CD55 Antibody Consumption Value by Application (2018-2029)
  • 9.3 South America CD55 Antibody Market Size by Country
    • 9.3.1 South America CD55 Antibody Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil CD55 Antibody Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina CD55 Antibody Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa CD55 Antibody Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa CD55 Antibody Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa CD55 Antibody Market Size by Country
    • 10.3.1 Middle East & Africa CD55 Antibody Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey CD55 Antibody Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia CD55 Antibody Market Size and Forecast (2018-2029)
    • 10.3.4 UAE CD55 Antibody Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 CD55 Antibody Market Drivers
  • 11.2 CD55 Antibody Market Restraints
  • 11.3 CD55 Antibody Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 CD55 Antibody Industry Chain
  • 12.2 CD55 Antibody Upstream Analysis
  • 12.3 CD55 Antibody Midstream Analysis
  • 12.4 CD55 Antibody Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on CD55 Antibody. Industry analysis & Market Report on CD55 Antibody is a syndicated market report, published as Global CD55 Antibody Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of CD55 Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo